首页> 外国专利> COMPOSITE BIOMATERIALS FOR PREVENTING POST-SURGICAL ADHESIONS OF TISSUES

COMPOSITE BIOMATERIALS FOR PREVENTING POST-SURGICAL ADHESIONS OF TISSUES

机译:预防组织在手术后粘连的复合生物材料

摘要

A composite biomaterial for preventing surgical adhesions of tissue comprised of at least one hyaluronic acid derivative selected from the group consisting of: (a) a benzyl ester of hyaluronic acid wherein 75 to 100% of the carboxyl groups of hyaluronic acid are esterified with a benzyl radical and up to 25% of the carboxyl groups are esterified with the alkyl radical of a C10 to C20 aliphatic alcohol, with the proviso that at least 80% of the carboxyl groups are esterified; and (b) an auto-crosslinked derivative of hyaluronic acid wherein 0.5 to 20% of the carboxyl groups of hyaluronic acid are crosslinked to the hydroxyl group of the same or different hyaluronic acid molecule, wherein said biomaterial is in the form of a gel, a membrane or a flat mesh, or a flat woven or non-woven tissue and combinations thereof, and further wherein said biomaterial does not contain either HYAFF7 (100% ethyl ester of hyaluronic acid) or a HYAFF11p75 (75% esterified benzyl ester of hyaluronic acid).
机译:一种用于防止组织的外科手术粘连的复合生物材料,其包含至少一种选自以下的透明质酸衍生物:(a)透明质酸的苄基酯,其中75-100%的透明质酸的羧基被苄基酯化。自由基和至多25%的羧基被C10至C20脂肪醇的烷基酯化,前提是至少80%的羧基被酯化; (b)透明质酸的自交联衍生物,其中0.5至20%的透明质酸的羧基与相同或不同透明质酸分子的羟基交联,其中所述生物材料为凝胶形式,膜或平坦的网眼,或平坦的编织或无纺布组织及其组合,并且其中所述生物材料不包含HYAFF7(100%透明质酸乙酯)或HYAFF11p75(75%的透明质酸酯化苄基酯)酸)。

著录项

  • 公开/公告号IL123500B

    专利类型

  • 公开/公告日2003-06-24

    原文格式PDF

  • 申请/专利权人 FIDIA ADVANCED BIOPOLYMERS S.R.L.;

    申请/专利号IL123500

  • 发明设计人

    申请日1996-08-29

  • 分类号A61L31/00;C09J189/00;

  • 国家 IL

  • 入库时间 2022-08-22 00:02:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号